Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1985 Sep;86(1):131–139. doi: 10.1111/j.1476-5381.1985.tb09443.x

Experimental testing of Mackay's model for functional antagonism in the isolated costo-uterus of the rat.

P J Henry, K M Lulich, J W Paterson
PMCID: PMC1916845  PMID: 3840396

Abstract

Several key predictions of a recently developed model for functional antagonism (Mackay, 1981) were experimentally tested using the rat isolated costo-uterine preparation. In the presence of the functional antagonist fenoterol (Fen), the functional constants (KAF) for carbachol and oxotremorine (Oxo) were respectively 9.9 and 3.4 fold greater than their corresponding affinity constants (KA). According to Mackay's model for functional antagonism, the higher KAF/KA ratio for carbachol indicates that this cholinoceptor agonist has a greater efficacy than Oxo. This was confirmed by using conventional pharmacological methods. As predicted from the model of functional antagonism, the plot of KAF/KA-1 against the fraction of cholinoceptors not irreversibly blocked by phenoxybenzamine (Pbz) was linear for both carbachol and Oxo and the lines of best fit crossed the axes at a point not significantly different from the origin. The value of 4.6 for the relative efficacy of carbachol to Oxo estimated from functional antagonism studies was comparable to the value of 5.6 calculated using the method of irreversible antagonism proposed by Furchgott (1966).

Full text

PDF
131

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amidon G. L., Buckner C. K. A theoretical model for the use of functional antagonism to estimate dissociation constants for agonists. J Pharmacol Methods. 1982 Mar;7(2):173–178. doi: 10.1016/0160-5402(82)90030-4. [DOI] [PubMed] [Google Scholar]
  2. DeLean A., Munson P. J., Rodbard D. Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. Am J Physiol. 1978 Aug;235(2):E97–102. doi: 10.1152/ajpendo.1978.235.2.E97. [DOI] [PubMed] [Google Scholar]
  3. Emmerson J., Mackay D. A test of the null equation for functional antagonism. Br J Pharmacol. 1981 May;73(1):135–141. doi: 10.1111/j.1476-5381.1981.tb16782.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Furchgott R. F. Pharmacological characterization of receptors: its relation to radioligand-binding studies. Fed Proc. 1978 Feb;37(2):115–120. [PubMed] [Google Scholar]
  5. Mackay D. An analysis of functional antagonism and synergism. Br J Pharmacol. 1981 May;73(1):127–134. doi: 10.1111/j.1476-5381.1981.tb16781.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. McPherson G. A., Molenaar P., Raper C., Malta E. Analysis of dose-response curves and calculation of agonist dissociation constants using a weighted nonlinear curve fitting program. J Pharmacol Methods. 1983 Dec;10(4):231–241. doi: 10.1016/0160-5402(83)90017-7. [DOI] [PubMed] [Google Scholar]
  7. Ohashi M. Studies on the mode of antagonism between adrenergic beta-mimetics and beta-blocking agents (III). Functional antagonism between beta-mimetics and spasmogens. Jpn J Pharmacol. 1976 Jun;26(3):315–323. doi: 10.1254/jjp.26.315. [DOI] [PubMed] [Google Scholar]
  8. Ringdahl B. Determination of dissociation constants and relative efficacies of oxotremorine analogs at muscarinic receptors in the guinea-pig ileum by pharmacological procedures. J Pharmacol Exp Ther. 1984 Apr;229(1):199–206. [PubMed] [Google Scholar]
  9. Ringdahl B., Jenden D. J. Pharmacological properties of oxotremorine and its analogs. Life Sci. 1983 May 23;32(21):2401–2413. doi: 10.1016/0024-3205(83)90365-x. [DOI] [PubMed] [Google Scholar]
  10. Takeyasu K., Uchida S., Wada A., Maruno M., Lai R. T., Hata F., Yoshida H. Experimental evidence and dynamic aspects of spare receptor. Life Sci. 1979 Nov 12;25(20):1761–1771. doi: 10.1016/0024-3205(79)90480-6. [DOI] [PubMed] [Google Scholar]
  11. van den Brink F. G., Offermeier J., Griessel H. J. Sensitization of contracted tracheal smooth muscle to beta-adrenergic spasmolysis by subthreshold doses of papaverine. Scand J Respir Dis Suppl. 1977;98:47–50. [PubMed] [Google Scholar]
  12. van den Brink F. G. The model of functional interaction. I. Development and first check of a new model of functional synergism and antagonism. Eur J Pharmacol. 1973 Jun;22(3):270–278. doi: 10.1016/0014-2999(73)90026-5. [DOI] [PubMed] [Google Scholar]
  13. van den Brink F. G. The model of functional interaction. II. Experimental verification of a new model: the antagonism of beta-adrenoceptor stimulants and other agonists. Eur J Pharmacol. 1973 Jun;22(3):279–286. doi: 10.1016/0014-2999(73)90027-7. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES